Close menu




Comments

Photo credits: pixabay.com

Commented by Armin Schulz on March 9th, 2022 | 13:14 CET

BP, Saturn Oil + Gas, Shell - Oil as the winner of the crisis

  • Oil

There are increasing signs that the EU wants to free itself from Russian oil and gas supplies as quickly as possible. Bloomberg writes that they want to cut back supplies by 80% within a year. Other sources report over 66%. If Russia is subject to an oil and gas embargo, there is a risk that commodity prices in these areas will continue to rise significantly. Even the US is currently considering an import ban on Russian oil. Since then, there has been no stopping the oil price. The primary beneficiaries are the oil and gas producers, three of which we are taking a closer look at today.

Read

Commented by André Will-Laudien on March 9th, 2022 | 12:56 CET

Panic oil price USD 130: Volkswagen, Porsche, Nevada Copper, Mercedes - Next push for e-mobility!

  • Copper
  • Electromobility

The panic moves in the oil and gas markets are making a trend increasingly apparent: For raw material importers, the historical dependence on fossil fuels is becoming unaffordable. Consequently, alternative energy and drive concepts are enjoying a renaissance, and GreenTech stocks are already the big winners. The same applies to copper: It is an essential metal for the high-tech industry due to its extreme conductivity. There has been a supply deficit since 2019, and the price has already quintupled in the years 2020 to early 2022. Who will close the dramatic gap?

Read

Commented by Carsten Mainitz on March 9th, 2022 | 12:14 CET

Kleos Space, Palantir, Deutsche Bank - Data like gold

  • Space
  • Software

The nervousness caused by the dramatic situation in Ukraine is also spreading to the global capital markets. Germany's leading index, the DAX, fell to a new low for the year of 12,431.50 points. By contrast, gold, the crisis currency, was bullish and put an initial exclamation mark above the USD 2,000 per ounce mark. Data providers such as Kleos Space and Palantir, whose Gotham software provides analyses for the US armed forces, among others, are also in demand.

Read

Commented by Stefan Feulner on March 9th, 2022 | 11:11 CET

McDonald's, Barsele Minerals, ING Group - Golden instead of Chicken McNugget

  • Gold

The crisis currency gold has already marked new all-time highs in the euro currency. In the case of the dollar, the precious metal moved above the psychologically important USD 2,000 mark, at least briefly. From a technical perspective, the next target is the high at USD 2,074.40. Various companies currently have entirely different concerns with regard to their high exposure to Russia. In contrast to other competitors, fast-food giant McDonald's is being hit extremely hard.

Read

Commented by Nico Popp on March 9th, 2022 | 10:06 CET

Is this how Kostolany would invest? BASF, Globex Mining, Gazprom

  • Commodities

War only knows losers. On the stock exchange, however, things look a little different. The stock market reflects tomorrow's changes today and ensures the allocation of capital. When money flows from one sector to another, opportunities also arise for investors. Those who bet on the right horse at the right time, win. Those who make the mistake of betting on the high flyers of the past may experience a financial Waterloo.

Read

Commented by Juliane Zielonka on March 8th, 2022 | 13:30 CET

First Hydrogen, Tesla, Toyota - Hydrogen leads the way in logistics

  • Hydrogen

For today's International Women's Day, we look at the discoverers of hydrogen sources. There are virtually no climate-damaging emissions where hydrogen is already being used as a form of propulsion today. First Hydrogen is a company that has chosen hydrogen-powered logistics vans as its niche to bring providers like Amazon and UPS up to speed. Things are finally getting mobile at the Gigafactory just outside Berlin, as Elon Musk gets the green light for the start-up. Meanwhile, Toyota's assembly line is at a standstill due to a cyberattack. The Japanese carmaker is also struggling with an emissions scandal involving a subsidiary.

Read

Commented by Fabian Lorenz on March 8th, 2022 | 12:07 CET

Nel, Hensoldt, Perimeter Medical: Hype share or sustainably attractive?

  • medtech
  • Technology
  • defense
  • Hydrogen

Since Russia's attack on Ukraine, the world has turned upside down. Also, the stock market. The volatility is extreme, as is the uncertainty of many investors. It is worth taking a look at companies in sectors with good long-term prospects. More than ever, these include renewable energies and, as of almost two weeks ago, "unfortunately" also the defense industry. Hydrogen is a key technology, and Nel ASA is a specialist in this field. However, insider sales are causing uncertainty. The same happened at Hensoldt after a major shareholder cashed in - but only for a short time. Medical technology is on the sidelines these days, although companies like Perimeter are working on life-saving technologies.

Read

Commented by André Will-Laudien on March 8th, 2022 | 11:03 CET

Rheinmetall, Altech Advanced Materials, Varta, Standard Lithium - Who can deliver?

  • Technology
  • Electromobility

Oil, gas, steel, and wheat - these are the goods that are becoming extremely scarce due to the Ukraine crisis. Scarce in the sense of expensive. Because, in the case of oil, OPEC does not yet want to adjust its production quotas. After all, they are currently earning splendidly with prices of up to USD 135 for Brent. Russia and Ukraine are important producers of steel and wheat, in addition to their 11% market share in oil and gas production. Steel is likely to be real short supply, as the start-up of several idle blast furnaces will take the West some time. And as for wheat, the futures market tells us it is up 46% this year. So it is clear the commodity rally and supply chain theme continues. Which companies should we be paying attention to?

Read

Commented by Armin Schulz on March 7th, 2022 | 13:05 CET

Valneva, Defence Therapeutics, MorphoSys - Blockbuster potential

  • Biotechnology

Every pharmaceutical or biotech company wants a blockbuster. This term refers to a drug that generates annual sales of at least USD 1 billion. The best-known blockbuster drug currently is the Corona vaccine from BioNTech. In 2020, the rheumatism drug Humira was in the top spot with sales of over USD 20 billion. The Mainz-based vaccine manufacturer is likely to have significantly surpassed this mark in 2021. If a company hits the big time, it can reap the rewards for 20 years before the patent expires. Today, we take a look at three companies that have potential blockbusters.

Read

Commented by André Will-Laudien on March 7th, 2022 | 12:48 CET

Attention: Nordex, Siemens Energy, Memiontec, Siemens - Out of the crisis with GreenTech!

  • GreenTech

Renewable energies promise lower and more stable energy prices in the medium term and greater independence from oil and gas from abroad. Accordingly, the current developments could lead to a further intensification of efforts for the energy turnaround in Europe. The armed conflicts between important raw material suppliers expose the risks of historical dependencies. For an energy importer like Germany, ongoing sanctions can pose a serious supply threat. Currently, the government may even be called upon to reduce levy-induced additional costs on fuels and postpone the phase-out of nuclear energy. In this mixed situation, GreenTech manufacturers will experience a real boost. We show which values are interesting.

Read